Global Neurodiagnostics Market to Reach $13.7 Billion by 2030

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

| Source: ReportLinker ReportLinker

New York, May 17, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Neurodiagnostics Industry" - https://www.reportlinker.com/p06032331/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Neurodiagnostics Market to Reach $13.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Neurodiagnostics estimated at US$7.5 Billion in the year 2022, is projected to reach a revised size of US$13.7 Billion by 2030, growing at aCAGR of 7.8% over the period 2022-2030. Diagnostic Imaging Systems, one of the segments analyzed in the report, is projected to record 8.2% CAGR and reach US$9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the In-vitro diagnostics (IVD) segment is readjusted to a revised 7.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2 Billion, While China is Forecast to Grow at 12.3% CAGR

The Neurodiagnostics market in the U.S. is estimated at US$2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 12.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 6.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Select Competitors (Total 33 Featured)
- Advanced Brain Monitoring
- ANT Neuro
- Bio-Rad Laboratories
- Canon, Inc.
- DRG Instruments GmbH
- Elmiko Medical Sp. Z o.o.
- Fonar Corporation
- Fujifilm Holdings Corporation
- Fujirebio
- GE Healthcare
- Hitachi, Ltd.
- Hoffman-La Roche AG
- Lifelines Neuro Company, LLC
- Mitsar Co., Ltd.
- Motion Lab Systems, Inc.
- Natus Medical Incorporated
- Neusoft Medical Systems Co., Ltd.
- Nihon Kohden Corporation
- Philips Healthcare
- Qiagen N.V.
- Ridge Diagnostics
- Rigaku Corporation
- Siemens Healthineers
- Tecan Trading AG
- Thermo Fisher Scientific, Inc.


Read the full report: https://www.reportlinker.com/p06032331/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Neurodiagnostics - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Neurodiagnostics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Neurodiagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 3: World 16-Year Perspective for Neurodiagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2014, 2023 & 2030

Table 4: World Recent Past, Current & Future Analysis for
Diagnostic Imaging Systems by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 5: World Historic Review for Diagnostic Imaging Systems
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 6: World 16-Year Perspective for Diagnostic Imaging
Systems by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 7: World Recent Past, Current & Future Analysis for
Hospitals & Surgery Centers by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 8: World Historic Review for Hospitals & Surgery Centers
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 9: World 16-Year Perspective for Hospitals & Surgery
Centers by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 10: World Recent Past, Current & Future Analysis for
Neurology Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 11: World Historic Review for Neurology Centers by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Neurology Centers by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 14: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 15: World 16-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Neuro Degenerative Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 17: World Historic Review for Neuro Degenerative Diseases
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Neuro Degenerative
Diseases by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 19: World Recent Past, Current & Future Analysis for
Epilepsy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 20: World Historic Review for Epilepsy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Epilepsy by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Stroke by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR

Table 23: World Historic Review for Stroke by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Stroke by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Headache Disorders by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 26: World Historic Review for Headache Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 27: World 16-Year Perspective for Headache Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Sleep Disorders by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 29: World Historic Review for Sleep Disorders by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 30: World 16-Year Perspective for Sleep Disorders by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for
Other Conditions by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR

Table 32: World Historic Review for Other Conditions by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 33: World 16-Year Perspective for Other Conditions by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030

Table 34: World Neurodiagnostics Market Analysis of Annual
Sales in US$ Million for Years 2014 through 2030

Table 35: World Recent Past, Current & Future Analysis for
In-vitro diagnostics (IVD) by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2022 through 2030 and % CAGR

Table 36: World Historic Review for In-vitro diagnostics (IVD)
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 37: World 16-Year Perspective for In-vitro diagnostics
(IVD) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2014, 2023 &
2030

Table 38: World Recent Past, Current & Future Analysis for
Diagnostic Laboratories & Imaging Centers by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2022 through 2030 and
% CAGR

Table 39: World Historic Review for Diagnostic Laboratories &
Imaging Centers by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 40: World 16-Year Perspective for Diagnostic Laboratories &
Imaging Centers by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2014, 2023 & 2030

III. MARKET ANALYSIS

UNITED STATES
Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United States for 2023 (E)
Table 41: USA Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Neurodiagnostics by Product -
Diagnostic Imaging Systems and In-vitro diagnostics (IVD)
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 43: USA 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 44: USA Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 45: USA Historic Review for Neurodiagnostics by End-Use -
Hospitals & Surgery Centers, Neurology Centers, Other End-Uses
and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 46: USA 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 47: USA Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 48: USA Historic Review for Neurodiagnostics by Condition -
Neuro Degenerative Diseases, Epilepsy, Stroke, Headache
Disorders, Sleep Disorders and Other Conditions Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 49: USA 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

CANADA
Table 50: Canada Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 51: Canada Historic Review for Neurodiagnostics by
Product - Diagnostic Imaging Systems and In-vitro diagnostics
(IVD) Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 52: Canada 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 53: Canada Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 54: Canada Historic Review for Neurodiagnostics by
End-Use - Hospitals & Surgery Centers, Neurology Centers, Other
End-Uses and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 55: Canada 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 56: Canada Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 57: Canada Historic Review for Neurodiagnostics by
Condition - Neuro Degenerative Diseases, Epilepsy, Stroke,
Headache Disorders, Sleep Disorders and Other Conditions
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 58: Canada 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

JAPAN
Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Japan for 2023 (E)
Table 59: Japan Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Neurodiagnostics by Product -
Diagnostic Imaging Systems and In-vitro diagnostics (IVD)
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 61: Japan 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 62: Japan Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 63: Japan Historic Review for Neurodiagnostics by End-Use -
Hospitals & Surgery Centers, Neurology Centers, Other
End-Uses and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 64: Japan 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 65: Japan Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 66: Japan Historic Review for Neurodiagnostics by
Condition - Neuro Degenerative Diseases, Epilepsy, Stroke,
Headache Disorders, Sleep Disorders and Other Conditions
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 67: Japan 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

CHINA
Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in China for 2023 (E)
Table 68: China Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 69: China Historic Review for Neurodiagnostics by Product -
Diagnostic Imaging Systems and In-vitro diagnostics (IVD)
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 70: China 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 71: China Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 72: China Historic Review for Neurodiagnostics by End-Use -
Hospitals & Surgery Centers, Neurology Centers, Other
End-Uses and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 73: China 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 74: China Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 75: China Historic Review for Neurodiagnostics by
Condition - Neuro Degenerative Diseases, Epilepsy, Stroke,
Headache Disorders, Sleep Disorders and Other Conditions
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 76: China 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

EUROPE
Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Europe for 2023 (E)
Table 77: Europe Recent Past, Current & Future Analysis for
Neurodiagnostics by Geographic Region - France, Germany, Italy,
UK, Spain, Russia and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2022 through
2030 and % CAGR

Table 78: Europe Historic Review for Neurodiagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2014 through 2021 and % CAGR

Table 79: Europe 16-Year Perspective for Neurodiagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2014, 2023 & 2030

Table 80: Europe Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Neurodiagnostics by
Product - Diagnostic Imaging Systems and In-vitro diagnostics
(IVD) Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 82: Europe 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 83: Europe Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 84: Europe Historic Review for Neurodiagnostics by
End-Use - Hospitals & Surgery Centers, Neurology Centers, Other
End-Uses and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 85: Europe 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 86: Europe Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 87: Europe Historic Review for Neurodiagnostics by
Condition - Neuro Degenerative Diseases, Epilepsy, Stroke,
Headache Disorders, Sleep Disorders and Other Conditions
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 88: Europe 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

FRANCE
Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in France for 2023 (E)
Table 89: France Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 90: France Historic Review for Neurodiagnostics by
Product - Diagnostic Imaging Systems and In-vitro diagnostics
(IVD) Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 91: France 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 92: France Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 93: France Historic Review for Neurodiagnostics by
End-Use - Hospitals & Surgery Centers, Neurology Centers, Other
End-Uses and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 94: France 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 95: France Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 96: France Historic Review for Neurodiagnostics by
Condition - Neuro Degenerative Diseases, Epilepsy, Stroke,
Headache Disorders, Sleep Disorders and Other Conditions
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 97: France 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

GERMANY
Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in Germany for 2023 (E)
Table 98: Germany Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 99: Germany Historic Review for Neurodiagnostics by
Product - Diagnostic Imaging Systems and In-vitro diagnostics
(IVD) Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 100: Germany 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 101: Germany Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 102: Germany Historic Review for Neurodiagnostics by
End-Use - Hospitals & Surgery Centers, Neurology Centers, Other
End-Uses and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 103: Germany 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 104: Germany Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 105: Germany Historic Review for Neurodiagnostics by
Condition - Neuro Degenerative Diseases, Epilepsy, Stroke,
Headache Disorders, Sleep Disorders and Other Conditions
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 106: Germany 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

ITALY
Table 107: Italy Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 108: Italy Historic Review for Neurodiagnostics by
Product - Diagnostic Imaging Systems and In-vitro diagnostics
(IVD) Markets - Independent Analysis of Annual Sales in US$
Million for Years 2014 through 2021 and % CAGR

Table 109: Italy 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic
Imaging Systems and In-vitro diagnostics (IVD) for the Years
2014, 2023 & 2030

Table 110: Italy Recent Past, Current & Future Analysis for
Neurodiagnostics by End-Use - Hospitals & Surgery Centers,
Neurology Centers, Other End-Uses and Diagnostic Laboratories &
Imaging Centers - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 111: Italy Historic Review for Neurodiagnostics by
End-Use - Hospitals & Surgery Centers, Neurology Centers, Other
End-Uses and Diagnostic Laboratories & Imaging Centers Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR

Table 112: Italy 16-Year Perspective for Neurodiagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals &
Surgery Centers, Neurology Centers, Other End-Uses and
Diagnostic Laboratories & Imaging Centers for the Years 2014,
2023 & 2030

Table 113: Italy Recent Past, Current & Future Analysis for
Neurodiagnostics by Condition - Neuro Degenerative Diseases,
Epilepsy, Stroke, Headache Disorders, Sleep Disorders and Other
Conditions - Independent Analysis of Annual Sales in US$
Million for the Years 2022 through 2030 and % CAGR

Table 114: Italy Historic Review for Neurodiagnostics by
Condition - Neuro Degenerative Diseases, Epilepsy, Stroke,
Headache Disorders, Sleep Disorders and Other Conditions
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 115: Italy 16-Year Perspective for Neurodiagnostics by
Condition - Percentage Breakdown of Value Sales for Neuro
Degenerative Diseases, Epilepsy, Stroke, Headache Disorders,
Sleep Disorders and Other Conditions for the Years 2014, 2023 &
2030

UNITED KINGDOM
Neurodiagnostics Market Presence - Strong/Active/Niche/Trivial -
Key Competitors in the United Kingdom for 2023 (E)
Table 116: UK Recent Past, Current & Future Analysis for
Neurodiagnostics by Product - Diagnostic Imaging Systems and
In-vitro diagnostics (IVD) - Independent Analysis of Annual
Sales in US$ Million for the Years 2022 through 2030 and % CAGR

Table 117: UK Historic Review for Neurodiagnostics by Product -
Diagnostic Imaging Systems and In-vitro diagnostics (IVD)
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR

Table 118: UK 16-Year Perspective for Neurodiagnostics by
Product - Percentage Breakdown of Value Sales for Diagnostic

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032331/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

 

            











    

        

        
Contact Data